Clinical Updates

Ritalin may help improve brain function in adolescent rats that were iron deficient during infancy, according to a team of… »   

A new study highlights inconsistencies in black box warnings - medication-related safety warnings on a drug’s label - and argues… »   

U.S. health regulators rejected Orexigen Therapeutics Inc’s weight-loss drug and requested a clinical trial to resolve heart safety concerns, dealing… »   

Sustained high vaccination coverage is key to preventing deaths from measles. Despite the availability of a vaccine, measles remains an… »   

The ability of some forms of plankton and bacteria to build an extra natural layer of nanoparticle-like armour has inspired… »   

In a study published today in Science (e-publication ahead of print), a global research team reports that the cancer… »   

Drugmakers AstraZeneca, Novartis and Eli Lilly set a cautious tone for 2011, bracing the sector for challenging patent expiries and… »   

U.S. health regulators declined to approve GlaxoSmithKline’s Avodart enlarged prostate drug for reducing the risk of prostate cancer in men… »   

A joint venture between U.S. drugmaker Merck and Britain’s Wellcome Trust charity said on Monday it is working on an… »   

An anesthetic used in lethal injections will no longer be made by its only U.S. manufacturer because the company does… »   

Countries that vaccinate babies against rotavirus, which can cause severe diarrhea and kill in days, have significantly reduced the number… »   

Merck & Co’s experimental blood clot preventer vorapaxar can cause bleeding in patients who previously suffered a stroke, investigators involved… »   

There is not enough data to prove widely used anemia drugs made by Amgen Inc and Johnson & Johnson improve… »   

Johnson & Johnson, already under fire for a string of product recalls, has another public relations issue on its hands… »   

A cheap generic drug used to stem bleeding from heavy menstrual periods could save the lives of tens of thousands… »